Seeing Is Believing
Currently out of the existing stock ratings of Catherine Novack, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).
Analyst Catherine Novack, currently employed at JONESTRADING, carries an average stock price target met ratio of 31.25% that have a potential upside of 53.11% achieved within 105 days.
Catherine Novack’s has documented 27 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CAPR, Capricor Therapeutics at 24-Jun-2025.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 8/9/2024. The price target of $12 was fulfilled within 68 days with a profit of $6.59 (121.81%) receiving and performance score of 17.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$8
$5.88 (277.36%)
1 months 8 days ago
(03-Sep-2025)
1/2 (50%)
$5.87 (275.59%)
660
Buy
$12
$9.88 (466.04%)
$12
6 months 11 days ago
(31-Mar-2025)
0/5 (0%)
$9.1 (313.79%)
Buy
$13
$10.88 (513.21%)
1 years 1 months 26 days ago
(15-Aug-2024)
0/1 (0%)
$9.43 (264.15%)
Buy
$3
$0.09 (3.09%)
1 years 4 months 27 days ago
(15-May-2024)
2/2 (100%)
$-1.32 (-30.56%)
135
Buy
$2
$-0.12 (-5.66%)
2 years 1 months 12 days ago
(29-Aug-2023)
1/1 (100%)
$-6.52 (-76.53%)
709
Which stock is Catherine Novack is most bullish on?
Which stock is Catherine Novack is most reserved on?
What Year was the first public recommendation made by Catherine Novack?